Literature DB >> 11302641

Subarachnoid-pleural fistula treated with noninvasive positive-pressure ventilation. Case report.

D Yoshor1, J B Gentry, S A LeMaire, J Dickerson, J Saul, A B Valadka, C S Robertson.   

Abstract

The authors describe the case of a 24-year-old man who underwent an L-1 corpectomy for spinal decompression and stabilization following an injury that caused an L-1 burst fracture. Postoperatively, an accumulation of spinal fluid developed in the pleural space, which was refractory to 1 week of thoracostomy tube drainage and lumbar cerebrospinal fluid (CSF) diversion. The authors then initiated a regimen of positive-pressure ventilation in which a bi-level positive airway pressure (PAP) mask was used. After 5 days, the CSF collection in the pleural space resolved. Use of a bi-level PAP mask represents a safe, noninvasive method of reducing the negative intrathoracic pressure that promotes CSF leakage into the pleural cavity and may be a useful adjunct in the treatment of subarachnoid-pleural fistula.

Entities:  

Mesh:

Year:  2001        PMID: 11302641     DOI: 10.3171/spi.2001.94.2.0319

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  [Delayed low CSF pressure syndrome: following a traumatic subarachnoid-pleural fistula after fracture of the 11th thoracic vertebra].

Authors:  A Waschke; S Müller; R Kalff; C Ewald
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

2.  Diagnose and treatment of traumatic pleural-subarachnoid fistula in children: A case report and systematic review.

Authors:  Ming Ge; Qi Zeng; Wei Yang; Chenghao Chen
Journal:  Chin Neurosurg J       Date:  2020-08-06

3.  Subarachnoidal pleural fistula after resection of intradural thoracic disc herniation and multimodal treatment with noninvasive positive pressure ventilation (NPPV).

Authors:  Holger R Schlag; Samiul Muquit; Tanyo B Hristov; Guiseppe Morassi; Bronek Maximilian Boszczyk; Masood Shafafy
Journal:  Eur Spine J       Date:  2015-07-28       Impact factor: 3.134

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.